Cross Country Healthcare, Inc. (CCRN) Coverage Initiated by Analysts at Credit Suisse Group

Research analysts at Credit Suisse Group initiated coverage on shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN) in a note issued to investors on Tuesday, November 7th, MarketBeat.com reports. The firm set a “neutral” rating and a $13.00 price target on the business services provider’s stock. Credit Suisse Group’s target price would suggest a potential downside of 4.20% from the stock’s current price.

Other research analysts have also issued research reports about the company. Zacks Investment Research upgraded Cross Country Healthcare from a “hold” rating to a “buy” rating and set a $13.00 price objective on the stock in a report on Monday, August 7th. TheStreet upgraded Cross Country Healthcare from a “c+” rating to a “b” rating in a report on Wednesday, September 27th. Benchmark Co. restated a “buy” rating and issued a $17.00 price objective (down previously from $18.00) on shares of Cross Country Healthcare in a report on Wednesday, August 9th. BidaskClub downgraded Cross Country Healthcare from a “sell” rating to a “strong sell” rating in a research note on Monday, July 24th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $18.00 target price on shares of Cross Country Healthcare in a research note on Wednesday, November 1st. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $15.31.

Shares of Cross Country Healthcare (NASDAQ CCRN) opened at $13.57 on Tuesday. Cross Country Healthcare has a one year low of $11.07 and a one year high of $16.38. The company has a market cap of $495.23, a P/E ratio of 21.20, a PEG ratio of 1.21 and a beta of 0.77. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.14 and a current ratio of 2.14.

Cross Country Healthcare (NASDAQ:CCRN) last announced its earnings results on Wednesday, November 1st. The business services provider reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $228.50 million for the quarter, compared to analyst estimates of $228.97 million. Cross Country Healthcare had a return on equity of 11.69% and a net margin of 0.19%. The business’s revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.24 EPS. research analysts forecast that Cross Country Healthcare will post 0.64 earnings per share for the current fiscal year.

In other Cross Country Healthcare news, Director Thomas C. Dircks acquired 10,000 shares of the business’s stock in a transaction that occurred on Monday, November 6th. The stock was purchased at an average cost of $11.77 per share, with a total value of $117,700.00. Following the transaction, the director now owns 104,571 shares of the company’s stock, valued at $1,230,800.67. The transaction was disclosed in a filing with the SEC, which is available at this link. 3.90% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. BNP Paribas Arbitrage SA grew its position in Cross Country Healthcare by 57.7% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 9,998 shares of the business services provider’s stock valued at $129,000 after acquiring an additional 3,660 shares in the last quarter. FDx Advisors Inc. acquired a new position in Cross Country Healthcare in the 3rd quarter valued at about $146,000. Strs Ohio boosted its stake in shares of Cross Country Healthcare by 69.5% in the 3rd quarter. Strs Ohio now owns 16,100 shares of the business services provider’s stock valued at $229,000 after buying an additional 6,600 shares during the period. Voya Investment Management LLC boosted its stake in shares of Cross Country Healthcare by 16.9% in the 2nd quarter. Voya Investment Management LLC now owns 18,329 shares of the business services provider’s stock valued at $237,000 after buying an additional 2,646 shares during the period. Finally, Los Angeles Capital Management & Equity Research Inc. purchased a new position in shares of Cross Country Healthcare in the 2nd quarter valued at about $246,000. 95.70% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This report was originally published by BBNS and is owned by of BBNS. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://baseballnewssource.com/markets/cross-country-healthcare-inc-ccrn-research-coverage-started-at-credit-suisse-group/1764916.html.

About Cross Country Healthcare

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.